StockNews.com Initiates Coverage on Global Cord Blood (NYSE:CO)

StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a report published on Saturday. The firm issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Shares of CO stock opened at $1.01 on Friday. The firm has a market cap of $122.77 million, a price-to-earnings ratio of 1.58 and a beta of 0.16. Global Cord Blood has a 52 week low of $2.03 and a 52 week high of $5.50. The firm’s 50-day simple moving average is $1.17 and its two-hundred day simple moving average is $1.39.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.